Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRESTA: Amantadine for Stroke Recovery
NCT05140148Phase 2Recruiting
- Sponsor
- University of Pennsylvania
- Start
- Feb 2022
- Primary completion
- Dec 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in stroke comparing Placebo with Amantadine (2 arms). Primary endpoint: Incidence of Treatment-Emergent Adverse Events at 90 days. Started Feb 2022; status: recruiting.
02
Drugs
amantadine
03
Conditions
stroke
Beyond the preview
Go deeper on NCT05140148.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05140148.